Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)

Author:

Szabo‐Reed Amanda N.12,Hall Tristyn3,Vidoni Eric D.14,Van Sciver Angela1,Sewell Monica5,Burns Jeffrey M.14,Cullum C. Munro67,Gahan William P.8,Hynan Linda S.69,Kerwin Diana R.1011,Rossetti Heidi6,Stowe Ann M.11,Vongpatanasin Wanpen8,Zhu David C.12,Zhang Rong37,Keller Jeffrey N.8,Binder Ellen F.5

Affiliation:

1. KU Alzheimer's Disease Research Center, University of Kansas Medical Center Fairway Kansas USA

2. Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA

3. Institute for Exercise and Environmental Medicine Texas Health Presbyterian Hospital Dallas Dallas USA

4. Department of Neurology University of Kansas Medical Center Kansas City Kansas USA

5. Department of Internal Medicine Division of Geriatrics & Nutritional Science Washington University School of Medicine in St. Louis St. Louis Missouri USA

6. Department of Psychiatry UT Southwestern Medical Center Dallas Texas USA

7. Department of Neurology UT Southwestern Medical Center Dallas Texas USA

8. Institute for Dementia Research and Prevention Pennington Biomedical Research Center Baton Rouge Louisiana USA

9. Peter O'Donnell Jr. School of Public Health UT Southwestern Medical Center Dallas Texas USA

10. Kerwin Research Center and Memory Care Dallas Texas USA

11. Department of Neurology University of Kentucky Lexington Kentucky USA

12. Department for Radiology Michigan State University East Lansing Michigan USA

Abstract

AbstractINTRODUCTIONThe risk reduction for Alzheimer's disease (rrAD) trial was a multisite clinical trial to assess exercise and intensive vascular pharmacological treatment on cognitive function in community‐dwelling older adults at increased risk for Alzheimer's disease.METHODSEligibility, consent, and randomization rates across different referral sources were compared. Informal interviews conducted with each site's project team were conducted upon study completion.RESULTSInitially, 3290 individuals were screened, of whom 28% were eligible to consent, 805 consented to participate (87.2% of those eligible), and 513 (36.3% of those consented) were randomized. Emails sent from study site listservs/databases yielded the highest amount (20.9%) of screened individuals. Professional referrals from physicians yielded the greatest percentage of consented individuals (57.1%). Referrals from non‐professional contacts (ie, friends, family; 75%) and mail/phone contact from a site (73.8%) had the highest yield of randomization.DISCUSSIONProfessional referrals or email from listservs/registries were most effective for enrolling participants. The greatest yield of eligible/randomized participants came from non‐professional and mail/phone contacts. Future trials should consider special efforts targeting these recruitment approaches.Highlights Clinical trial recruitment is commonly cited as a significant barrier to advancing our understanding of cognitive health interventions. The most cited referral source was email, followed by interviews/editorials on the radio, television, local newspapers, newsletters, or magazine articles. The referral method that brought in the largest number of contacts was email but did not result in the greatest yield of consents or eligible participants. The sources that yielded the greatest likelihood of consent were professional referrals (ie, physician), social media, and mail/phone contact from study site. The greatest yield of eligible/randomized participants came from non‐professional contacts and mail/phone contact from a site. Findings suggest that sites may need to focus on more selective referral sources, such as using contact mailing and phone lists, rather than more widely viewed recruitment sources, such as social media or TV/radio advertisements.

Funder

National Institutes of Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Practical social media recommendations for dementia prevention researchers;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3